María Soledad Benito-Martín
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
María Soledad Benito-Martín has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Ulises Gómez-Pinedo
Laboratorio de Neurobiología y Terapias Avanzadas, Instituto de Neurociencias, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos, 28040 Madrid, Spain
6 shared publications - Jordi A. Matias-Guiu
Hospital Clinico San Carlos
5 shared publications - Belen Selma-Calvo
Laboratorio de Neurobiología y Terapias Avanzadas, Instituto de Neurociencias, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos, 28040 Madrid, Spain
4 shared publications - Doddy Denise Ojeda-Hernández
Laboratorio de Neurobiología y Terapias Avanzadas, Instituto de Neurociencias, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos, 28040 Madrid, Spain
4 shared publications - Antonio Guerrero-Sola
Service of Neurology, Hospital Universitario San Carlos, Madrid, Spain
3 shared publications Antonio Ruiz de León
2 shared publications
Latest Publications
- Open Access
- 21 February 2025
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 24 (2) , 26429
Technical Assessment of Motor and Behavioral Tests in Rodent Models of Multiple Sclerosis
Background: Multiple sclerosis (MS) is a neurodegenerative disorder characterized by progressive motor and cognitive impairments, affecting millions worldwide. It significantly reduces patients’ quality of life and imposes a burden on health systems. Despite advances in understanding MS, there is no cure, highlighting the need for effective therapeutic strategies. Preclinical animal models are critical for gaining insights into MS pathophysiology and treatments. However, these models fail to fully replicate the complexity of human MS, making it essential to choose appropriate models and behavioral tests to evaluate their efficacy. Purpose: This review examines various motor and cognitive behavioral tests used in preclinical MS models, discussing their strengths and limitations. The goal is to guide researchers in selecting the most appropriate tests for their models, while providing insights into how these tests are performed and analyzed. Methods: We reviewed motor and cognitive behavioral tests used in MS models, detailing test procedures and evaluating their advantages and disadvantages. Results: This review offers a comprehensive overview that aids researchers in choosing the most suitable tests for their studies, improving the accuracy and reliability of preclinical MS research. Conclusions: Understanding the strengths and limitations of these tests is crucial for making informed decisions, leading to better experimental designs and, ultimately, more effective therapeutic interventions for MS.
- 21 February 2025
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 24 (2) , 26429
Open AccessTechnical Assessment of Motor and Behavioral Tests in Rodent Models of Multiple Sclerosis
Background: Multiple sclerosis (MS) is a neurodegenerative disorder characterized by progressive motor and cognitive impairments, affecting millions worldwide. It significantly reduces patients’ quality of life and imposes a burden on health systems. Despite advances in understanding MS, there is no cure, highlighting the need for effective therapeutic strategies. Preclinical animal models are critical for gaining insights into MS pathophysiology and treatments. However, these models fail to fully replicate the complexity of human MS, making it essential to choose appropriate models and behavioral tests to evaluate their efficacy. Purpose: This review examines various motor and cognitive behavioral tests used in preclinical MS models, discussing their strengths and limitations. The goal is to guide researchers in selecting the most appropriate tests for their models, while providing insights into how these tests are performed and analyzed. Methods: We reviewed motor and cognitive behavioral tests used in MS models, detailing test procedures and evaluating their advantages and disadvantages. Results: This review offers a comprehensive overview that aids researchers in choosing the most suitable tests for their studies, improving the accuracy and reliability of preclinical MS research. Conclusions: Understanding the strengths and limitations of these tests is crucial for making informed decisions, leading to better experimental designs and, ultimately, more effective therapeutic interventions for MS.
- Open Access
- 15 January 2025
- Published by Elsevier in Neurología
- Vol. 40 (1) , 10-21
Variant rs4149584 (R92Q) of the TNFRSF1A gene in patients with familial multiple sclerosis
- 15 January 2025
- Published by Elsevier in Neurología
- Vol. 40 (1) , 10-21
Open AccessVariant rs4149584 (R92Q) of the TNFRSF1A gene in patients with familial multiple sclerosis
- Open Access
- 7 September 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 188, 157-168
Thermosensitive chitosan-based hydrogel: A vehicle for overcoming the limitations of nose-to-brain cell therapy
- 7 September 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 188, 157-168
Open AccessThermosensitive chitosan-based hydrogel: A vehicle for overcoming the limitations of nose-to-brain cell therapy
- Open Access
- 10 August 2022
- Published by Elsevier in Neurología (English Edition)
- Vol. 40 (1) , 10-21
Variant rs4149584 (R92Q) of the TNFRSF1A gene in patients with familial multiple sclerosis
- 10 August 2022
- Published by Elsevier in Neurología (English Edition)
- Vol. 40 (1) , 10-21
Open AccessVariant rs4149584 (R92Q) of the TNFRSF1A gene in patients with familial multiple sclerosis
- Open Access
- 1 May 2018
- Published by Elsevier in Neurología
- Vol. 33 (4) , 211-223
La infusión intracerebroventricular prolongada de líquido cefalorraquídeo procedente de pacientes con esclerosis lateral amiotrófica provoca cambios histológicos en el cerebro y la médula espinal de la rata similares a los hallados en la enfermedad
- 1 May 2018
- Published by Elsevier in Neurología
- Vol. 33 (4) , 211-223
Open AccessLa infusión intracerebroventricular prolongada de líquido cefalorraquídeo procedente de pacientes con esclerosis lateral amiotrófica provoca cambios histológicos en el cerebro y la médula espinal de la rata similares a los hallados en la enfermedad
- Open Access
- 8 November 2016
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 7, 195
Immununochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases
Background: Several findings suggest that the amyloid precursor protein (APP) and the amyloid cascade may play a role in motor neuron disease (MND). Objective: Considering that dementia is one of the most frequently non-motor symptoms in ALS and that hippocampus is one of the brain areas with greater presence of amyloid related changes in neurodegenerative diseases, our aim was to analyse the molecular markers of the amyloid cascade of APP in pathology studies of the hippocampus of autopsied patients with ALS and ALS-FTD. Methods: We included 9 patients with MND and 4 controls. Immunohistochemical studies and confocal microscopy were used to analyse the expression of APP, TDP-43, pho-TDP-43, Aβ, AICD peptide, Fe65 protein, and pho-TAU in the hippocampus of 7 patients with ALS, 2 patients with ALS-FTD, and 4 controls. These findings were correlated with clinical data. Results: Patients displayed increased expression of APP and Aβ peptide. The latter was correlated with cytoplasmic pho-TDP-43 expression. We also found decreased Fe65 expression. A parallel increase in AICD expression was not found. Patients showed increased expression of pho-TAU in the hippocampus. Findings were similar in patients with ALS and those with ALS-FTD, though more marked in the latter group. Conclusion: Post-mortem analyses showed that the amyloid cascade is activated in the hippocampus of patients with MND and correlated with cytoplasmic pho-TDP-43 expression. The number of intra- or extracellular aggregates of Aβ peptides was not significant.
- 8 November 2016
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 7, 195
Open AccessImmununochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases
Background: Several findings suggest that the amyloid precursor protein (APP) and the amyloid cascade may play a role in motor neuron disease (MND). Objective: Considering that dementia is one of the most frequently non-motor symptoms in ALS and that hippocampus is one of the brain areas with greater presence of amyloid related changes in neurodegenerative diseases, our aim was to analyse the molecular markers of the amyloid cascade of APP in pathology studies of the hippocampus of autopsied patients with ALS and ALS-FTD. Methods: We included 9 patients with MND and 4 controls. Immunohistochemical studies and confocal microscopy were used to analyse the expression of APP, TDP-43, pho-TDP-43, Aβ, AICD peptide, Fe65 protein, and pho-TAU in the hippocampus of 7 patients with ALS, 2 patients with ALS-FTD, and 4 controls. These findings were correlated with clinical data. Results: Patients displayed increased expression of APP and Aβ peptide. The latter was correlated with cytoplasmic pho-TDP-43 expression. We also found decreased Fe65 expression. A parallel increase in AICD expression was not found. Patients showed increased expression of pho-TAU in the hippocampus. Findings were similar in patients with ALS and those with ALS-FTD, though more marked in the latter group. Conclusion: Post-mortem analyses showed that the amyloid cascade is activated in the hippocampus of patients with MND and correlated with cytoplasmic pho-TDP-43 expression. The number of intra- or extracellular aggregates of Aβ peptides was not significant.
- 1 July 2014
- Published by Elsevier in Neurología
- Vol. 29 (6) , 346-352
Cambios celulares producidos por la citotoxicidad del líquido cefalorraquídeo de pacientes con esclerosis lateral amiotrófica sobre cultivos de neuronas motoras
- 1 July 2014
- Published by Elsevier in Neurología
- Vol. 29 (6) , 346-352
Cambios celulares producidos por la citotoxicidad del líquido cefalorraquídeo de pacientes con esclerosis lateral amiotrófica sobre cultivos de neuronas motoras
- 1 September 2011
- Published by Elsevier in Human Immunology
- Vol. 72 (9) , 749-752
Association of IL10 promoter polymorphisms with idiopathic achalasia
- 1 September 2011
- Published by Elsevier in Human Immunology
- Vol. 72 (9) , 749-752
Association of IL10 promoter polymorphisms with idiopathic achalasia
- 1 June 2008
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 14 (5) , 595-601
Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients
Objective To analyze the possible role of human herpesvirus (HHVs) and human endogenous retroviruses (HERVs) infection in multiple sclerosis (MS) pathogenesis. Methods A total of 92 cerebrospinal fluid (CSF) samples were collected: 48 from MS patients at the first clinically evident demyelinating event, 23 from patients with other inflammatory neurological diseases (OINDs) and 21 from patients with other non-inflammatory neurological diseases (ONINDs). Total DNA and RNA were isolated, and the prevalences and viral loads of herpes simplex virus (HSV), varicella-zoster virus (VZV), Epstein–Barr virus (EBV), cytomegalovirus (CMV), HHV-6, HERV-H and HERV-W in the CSF of MS patients and controls were evaluated using a quantitative real-time polymerase chain reaction assay. Results (i) For HSV, 1/48 (2.1%, 86 copies/ml of CSF) MS patients and 1/23 (4.3%, 115.2 copies/ml of CSF) OIND patients (a myelitis case) had HSV sequences in the CSF; (ii) for EBV, only 1/48 (2.1%, 72 copies/ml of CSF) MS patients was positive for EBV; (iii) for HHV-6, only 5/48 (10.4%) MS patients had HHV-6 genomes in their CSF (128.1 copies/ml of CSF); (iv) we did not find any positive cases for VZV, CMV, HERV-H and HERV-W among MS patients or controls; (v) no cases of co-infections were found; (vi) the whole prevalence of HHVs was 7/48 (14.6%) for MS patients and 1/44 (2.3%) for controls (p = 0.038). Conclusion The findings described here show that HHV infection is more frequent in the CSF of MS patients than in patients with other neurological diseases; however, only HHV-6 seems to be involved in the pathogenesis of MS in a subset of patients.
- 1 June 2008
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 14 (5) , 595-601
Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients
Objective To analyze the possible role of human herpesvirus (HHVs) and human endogenous retroviruses (HERVs) infection in multiple sclerosis (MS) pathogenesis. Methods A total of 92 cerebrospinal fluid (CSF) samples were collected: 48 from MS patients at the first clinically evident demyelinating event, 23 from patients with other inflammatory neurological diseases (OINDs) and 21 from patients with other non-inflammatory neurological diseases (ONINDs). Total DNA and RNA were isolated, and the prevalences and viral loads of herpes simplex virus (HSV), varicella-zoster virus (VZV), Epstein–Barr virus (EBV), cytomegalovirus (CMV), HHV-6, HERV-H and HERV-W in the CSF of MS patients and controls were evaluated using a quantitative real-time polymerase chain reaction assay. Results (i) For HSV, 1/48 (2.1%, 86 copies/ml of CSF) MS patients and 1/23 (4.3%, 115.2 copies/ml of CSF) OIND patients (a myelitis case) had HSV sequences in the CSF; (ii) for EBV, only 1/48 (2.1%, 72 copies/ml of CSF) MS patients was positive for EBV; (iii) for HHV-6, only 5/48 (10.4%) MS patients had HHV-6 genomes in their CSF (128.1 copies/ml of CSF); (iv) we did not find any positive cases for VZV, CMV, HERV-H and HERV-W among MS patients or controls; (v) no cases of co-infections were found; (vi) the whole prevalence of HHVs was 7/48 (14.6%) for MS patients and 1/44 (2.3%) for controls (p = 0.038). Conclusion The findings described here show that HHV infection is more frequent in the CSF of MS patients than in patients with other neurological diseases; however, only HHV-6 seems to be involved in the pathogenesis of MS in a subset of patients.
- 1 October 2007
- Published by Elsevier in Human Immunology
- Vol. 68 (10) , 867-870
Gender-specific association of the PTPN22 C1858T polymorphism with achalasia
- 1 October 2007
- Published by Elsevier in Human Immunology
- Vol. 68 (10) , 867-870
Gender-specific association of the PTPN22 C1858T polymorphism with achalasia